Cargando…
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
BACKGROUND: Urine markers have been studied extensively but there is a lack of blood prognostic markers in bladder cancer. MMP-7 is produced by stromal cells and by tumor cells and is overexpressed in a variety of epithelial and mesenchymal tumors. In this study, we assessed with an immunoassay we d...
Autores principales: | El Demery, Mounira, Demirdjian-Sarkissian, Gaiané, Thezenas, Simon, Jacot, William, Laghzali, Yassine, Darbouret, Bruno, Culine, Stéphane, Rebillard, Xavier, Lamy, Pierre-Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410142/ https://www.ncbi.nlm.nih.gov/pubmed/25984271 http://dx.doi.org/10.1186/s40169-014-0031-4 |
Ejemplares similares
-
First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker
por: Tørring, Niels, et al.
Publicado: (2010) -
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
por: Darlix, Amélie, et al.
Publicado: (2016) -
Matrix Metalloproteinases and Bladder Cancer: What is New?
por: Rodriguez Faba, O., et al.
Publicado: (2012) -
The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023) -
Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
por: Bolenz, Christian, et al.
Publicado: (2018)